• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Satio wins $3.5M contract to develop at-home transdermal drug delivery device

September 28, 2023 By Sean Whooley

Satio SatioRx
The SatioRx transdermal drug delivery device. [Image from the company’s website]
Satio announced that a National Institutes for Health agency awarded it a $3.5 million Small Business Innovation Research (SBIR) contract.

Awarded by the NIH’s Advanced Research Projects Agency for Health (ARPA-H), the contract helps the company develop SatioRx. This drug delivery device, compact and inexpensive, features disposable microneedle components for precise delivery. It remotely enables the delivery of a precise, metered dose of any liquid drug approved for transdermal delivery.

Under the contract, Boston-based Satio expects to leverage design features from its other patch-based devices. It also plans to utilize feasibility data from its manually operated transdermal delivery devices. Combining these, the company intends to develop a next-generation, remotely controllable device.

Satio says topical patches rely on drug diffusion, differing from its microneedle-based transdermal system. This technology creates minute pathways through the epidermis to enable painless, direct drug delivery into the bloodstream. Because of its ability for at-home administration, it also tackles the challenges of treatment compliance.

The company says it also could positively impact the vaccine delivery market with its transdermal technology. Transdermal delivery previously showed a lower dose requirement achieving the same level of vaccine protection with fewer side effects. It also benefits children and those afraid of needles.

At-home delivery could also play a role in expanding immunization coverage, Satio says. This would prove especially beneficial in pandemic scenarios or in places with limited access to healthcare infrastructure.

“At-home drug and vaccine delivery offer transformational potential for better outcomes, efficiency, and lowering of overall costs of healthcare,” said Namal Nawana, Satio executive chair and founder. “The SatioRx novel design incorporates proprietary technologies to remotely deliver a broad range of drugs and vaccines transdermally.”

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Funding Roundup, Pharmaceuticals, Technology Tagged With: ARPA-H, National Institutes of Health, Satio

IN CASE YOU MISSED IT

  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes
  • Study backs Tandem automated insulin delivery in pregnant women with type 1 diabetes
  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Abbott could pave new roads in diabetes management with dual sensor on the horizon

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS